Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s New Acting Generics Chief Relearning System After 24 Years Of Experience
Nov 04 2022
•
By
Derrick Gingery
Susan Rosencrance has been acting OGD director for less than a month. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics